232 related articles for article (PubMed ID: 18294598)
21. [Prevention of stress ulcer: an essentially necessary measure in intensive care patients? Arguments contra].
Hannemann L; Kuss B; Eyrich K
Z Gastroenterol; 1991 Jan; 29 Suppl 1():7-8; discussion 9. PubMed ID: 1683735
[No Abstract] [Full Text] [Related]
22. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals.
den Elzen WP; Groeneveld Y; de Ruijter W; Souverijn JH; le Cessie S; Assendelft WJ; Gussekloo J
Aliment Pharmacol Ther; 2008 Mar; 27(6):491-7. PubMed ID: 18194503
[TBL] [Abstract][Full Text] [Related]
23. Long-term proton pump inhibitor therapy and risk of hip fracture.
Yang YX; Lewis JD; Epstein S; Metz DC
JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
[TBL] [Abstract][Full Text] [Related]
24. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
[TBL] [Abstract][Full Text] [Related]
25. The association of proton pump inhibitors and hypomagnesemia in the community setting.
Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
[TBL] [Abstract][Full Text] [Related]
26. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
27. Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina?
Tanaka S; Nishigaki K; Ojio S; Okubo M; Yasuda S; Ishihara Y; Kubota T; Takasugi N; Kawamura I; Yamaki T; Ushikoshi H; Aoyama T; Kawasaki M; Takemura G; Minatoguchi S
J Cardiol; 2008 Aug; 52(1):39-48. PubMed ID: 18639776
[TBL] [Abstract][Full Text] [Related]
28. [Prevention of stress ulcers with acid decreasing drugs: an effective and sensible therapeutic approach? Arguments contra].
Fritsch WP
Z Gastroenterol; 1991 Jan; 29 Suppl 1():12-3; discussion 14-5. PubMed ID: 1683732
[No Abstract] [Full Text] [Related]
29. [The risks of long-term proton pump inhibitors use].
Jiang X; Zhang Q; Zhang Z; Liu Y
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(4):284-8. PubMed ID: 24731496
[TBL] [Abstract][Full Text] [Related]
30. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
31. Vitamin B12 Deficiency: Recognition and Management.
Langan RC; Goodbred AJ
Am Fam Physician; 2017 Sep; 96(6):384-389. PubMed ID: 28925645
[TBL] [Abstract][Full Text] [Related]
32. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
[TBL] [Abstract][Full Text] [Related]
33. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
Kumar KR; Iqbal R; Coss E; Park C; Cryer B; Genta RM
Hum Pathol; 2013 Dec; 44(12):2706-10. PubMed ID: 24071014
[TBL] [Abstract][Full Text] [Related]
35. [Acid inhibition leads to vitamin b12 deficiency].
Zwicker J
Med Monatsschr Pharm; 2014 May; 37(5):190-1. PubMed ID: 24908938
[No Abstract] [Full Text] [Related]
36. Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.
Biswas S; Benedict SH; Lynch SG; LeVine SM
BMC Med; 2012 Jun; 10():57. PubMed ID: 22676575
[TBL] [Abstract][Full Text] [Related]
37. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
38. Associations of atrophic gastritis and proton-pump inhibitor drug use with vitamin B-12 status, and the impact of fortified foods, in older adults.
Porter KM; Hoey L; Hughes CF; Ward M; Clements M; Strain J; Cunningham C; Casey MC; Tracey F; O'Kane M; Pentieva K; McAnena L; McCarroll K; Laird E; Molloy AM; McNulty H
Am J Clin Nutr; 2021 Oct; 114(4):1286-1294. PubMed ID: 34134144
[TBL] [Abstract][Full Text] [Related]
39. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
40. Vitamin B12 deficiency in Australian residential aged care facilities.
Mirkazemi C; Peterson GM; Tenni PC; Jackson SL
J Nutr Health Aging; 2012 Mar; 16(3):277-80. PubMed ID: 22456786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
